About NCCU Academics Admissions Athletics Campus Life Giving Research

Pancreatic Cancer

Pancreatic ductal adenocarcinoma (PDAC) is highly aggressive and almost always fatal. Currently, there are no biomarkers for early detection and treatment options are very limited. Although the presence of oncogenically mutated K-Ras in 90% of PDAC strongly suggests a critical role for this genetic mutation in the development of this disease, to date no anti-Ras therapies have successfully reached the clinic. Antonio T. Baines’ lab is working to identify and validate the role of novel molecular targets in the development and transformation of normal pancreatic cells into pancreatic cancer.

 
NCCU complies with Title IX of the Education Amendments of 1972, which prohibits discrimination on the basis of sex in all programs and activities (including sexual harassment and sexual violence) in the University's educational programs and activities. For additional resources or to file a Title IX complaint, visit the NCCU's Title IX webpage.
© 2017 North Carolina Central University 1801 Fayetteville St., Durham, NC 27707